Search Results - Novak, Annoesjka

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands

    Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands by Pompen, Marjolein, Gok, Murat, Novák, Annoesjka, van Wuijtswinkel, Rob, Biesma, Bonne, Schramel, Franz, Stigt, Jos, Smit, Hans, Postmus, Pieter

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The Aging Males' Symptoms (AMS) scale: update and compilation of international versions

    The Aging Males' Symptoms (AMS) scale: update and compilation of international versions by Heinemann, Lothar A J, Saad, Farid, Zimmermann, Thomas, Novak, Annoesjka, Myon, Eric, Badia, Xavier, Potthoff, Peter, T'Sjoen, Guy, Pöllänen, Pasi, Goncharow, Nikolai P, Kim, Sehyun, Giroudet, Christelle

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing

    Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing by NOVAK, Annoesjka, DE LA LOGE, Christine, ABETZ, Linda

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

    Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands by Essers, Brigitte A.B., PhD, Seferina, Shanley C., MD, Tjan-Heijnen, Vivianne C.G., MD PhD, Severens, Johan L., PhD, Novák, Annoesjka, MSc, Pompen, Marjolein, PhD, Oron, Ulrich H., MhSc RPh MBA, Joore, Manuela A., PhD

    Published in Value in health
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Estimating the implicit value of statistical life based on public interventions implemented in The Netherlands

    Estimating the implicit value of statistical life based on public interventions implemented in The Netherlands by Goebbels, Adrienne F. G., Ament, André J. H. A., Novák, Annoesjka, Veraart, Christiaan P. W. M., Severens, Johan L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Andropause and quality of life: findings from patient focus groups and clinical experts

    Andropause and quality of life: findings from patient focus groups and clinical experts by Novák, Annoesjka, Brod, Meryl, Elbers, Jolanda

    Published in Maturitas
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands

    Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands by van Boven, Job F. M., Novak, Annoesjka, Driessen, Maurice T., Boersma, Cornelis, Boomsma, Maarten M., Postma, Maarten J.

    Published in Drugs & aging
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Economic evaluations of healthcare programmes and decision making : The influence of economic evaluations on different healthcare decision-making levels

    Economic evaluations of healthcare programmes and decision making : The influence of economic evaluations on different healthcare decision-making levels by VAN VELDEN, Marieke E, SEVERENS, Johan L, NOVAK, Annoesjka

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  9. 9
    PD6-3-5: Pharmacoeconomic analysis shows that erlotinib is cost-saving versus docetaxel, and cost-effective versus best supportive care (BSC) in NSCLC

    PD6-3-5: Pharmacoeconomic analysis shows that erlotinib is cost-saving versus docetaxel, and cost-effective versus best supportive care (BSC) in NSCLC by Pompen, Marjolein, Novak, Annoesjka, Gok, Murat, Gyldmark, Marlene, Postmus, Pieter, Afram, Charles

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza : Illustration for the netherlands

    Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza : Illustration for the netherl... by POSTMA, Maarten J, NOVAK, Annoesjka, SCHEIJBELER, Huib W. K. F. H, GYLDMARK, Marlene, VAN GENUGTEN, Marianne L. L, WILSCHUT, Jan C

    Published in PharmacoEconomics
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  11. 11
    Psychometric Validation of Contraceptive Ring Acceptability Questionnaire

    Psychometric Validation of Contraceptive Ring Acceptability Questionnaire by Annoesjka Novak, Linda Abetz, Christine de la Loge

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: